pipobroman has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orlandi, E | 1 |
| Bernasconi, P | 1 |
| Boni, M | 1 |
| Calatroni, S | 1 |
| Lazzarino, M | 1 |
| Tefferi, A | 1 |
2 other studies available for pipobroman and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
Topics: Aged; Antineoplastic Agents, Alkylating; Cytogenetic Analysis; Female; Fusion Proteins, bcr-abl; Hum | 2005 |
Is hydroxyurea leukemogenic in essential thrombocythemia?
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Bone Marrow; Busulfan; Chromosome Aberrations; Chr | 1998 |